Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Califf Optimistic As He Departs US FDA

Executive Summary

Outgoing commissioner highlights efforts to improve staff, says bucket list mostly accomplished. Agency now faces hiring freeze challenge.


Related Content

Drug Development, Not Conflicts, Dominates Gottlieb's Confirmation Hearing
Trump Takes Office, Change At US FDA Arrives With ‘Beachhead Teams’
US FDA Might Be Temporarily Headed By Ostroff As Califf Sets His Departure
US FDA’s OCI Director Is Leaving For Private Practice
Woodcock Tries To Calm US FDA Staff Fears About Trump
Woodcock, Califf Give Thumbs Up To Certain 21st Century Cures Provisions
The Evolution Of 21st Century Cures Legislation
Cures Bill Authorizes 'Intercenter Institutes,' But Will US FDA Create Them?
GDUFA II Will Include Small Business Relief, Priority ANDA Reviews
Robert Califf Wants You To Forget His Confirmation Hearing





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts